A $100 million BATWorks initiative will turn the Brooklyn Army Terminal into a climate tech testing ground, promising hundreds of local jobs and pilots ahead of a 2028 launch.

A Manhattan federal judge refused to dismiss a class action accusing CNN of sharing visitors’ browsing data with adtech firms, keeping alive a test of California’s pen‑register law.

The FCC added foreign-made consumer routers to its Covered List, blocking new models from receiving U.S. authorization. Existing devices remain usable but future upgrades may slow.

Stony Brook planetary scientist Timothy Glotch was chosen as a participating scientist on NASA’s Artemis lunar surface team. He’ll help plan and support astronaut science operations for the Artemis IV landing campaign.

A Manhattan scientist with a deadly family history of ALS has been receiving experimental spinal antisense infusions at Columbia; early tests show promise.

The Associated Press is offering buyouts to U.S. staff as it pivots to video and paid data products — a shift that could reshape local news coverage.

A fake CAPTCHA scam is tricking Windows users into pasting and running commands that install the StealC info‑stealer. Experts explain what it does and how to respond.

Pfizer and Valneva say their VLA15 Lyme vaccine is showing promise in late‑stage trials; a Phase 3 readout is expected in early 2026.

Abbott has closed its roughly $21B purchase of Exact Sciences, paying $105 a share and folding Cologuard and other cancer‑testing assets into its diagnostics arm while keeping Exact’s Madison operations intact.

An international drilling mission found low‑salinity water trapped beneath the Atlantic off New England. Early estimates say the supply could be huge — but tapping it would be complex.

Merlin Labs went public this week via a SPAC merger, listing on Nasdaq under MRLN and closing at $9.03. The Boston startup arrives with fresh capital and a $105M defense contract to accelerate hiring and certification.

Goldman Sachs is investing $42.5M in Chicago‑based GeoWealth to extend its Series C and deepen a product partnership aimed at RIAs.

Congress moved to restore SBIR/STTR authority, reopening non‑dilutive R&D grants that many New York biotech startups rely on.